Effects of human pharmaceuticals on aquatic life: next steps.
Cunningham
Virginia L
VL
GlaxoSmithKline. virginia.l.cunningham@gsk.com
Buzby
Mary
M
Hutchinson
Thomas
T
Mastrocco
Frank
F
Parke
Neil
N
Roden
Nicholas
N
D000818:Animals; D003621:Daphnia / Q000187:drug effects / Q000254:growth & development; D017753:Ecosystem; D004784:Environmental Monitoring / Q000379:methods* / Q000592:standards; D006801:Humans; D004364:Pharmaceutical Preparations / Q000032:analysis*; D018570:Risk Assessment / Q000379:methods / Q000639:trends; D012722:Sewage / Q000737:chemistry; D014874:Water Pollutants, Chemical / Q000032:analysis* / Q000633:toxicity; D014877:Water Pollution, Chemical / Q000517:prevention & control
D004364:Pharmaceutical Preparations; D012722:Sewage; D014874:Water Pollutants, Chemical